is glp-1 six in one a scam Inside Europe's AI-Fuelled Epidemic: How Criminal Networks Are Hijacking the Identities of the NHS, AEMPS, ANSM, BfArM and AIFA to Sell Fake Weight-Loss Products Stopping GLP-1s: Weight Regain and

Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus

A spokesperson for Eli Lilly, which produces Zepbound and Mounjaro, told The Independent that Zepbound and Mounjaro autoinjectors and Zepbound vials are approved for single-use onlydose-splitting or microdosing is not contemplated by the FDA-label and may pose patient safety risks. Novo Nordisk, which produces Ozempic and Wegovy, told The Independent the company "[does] not condone the misuse of our products." The company noted it is concerned about non-FDA approved knock-off versions of semaglutide and sources spreading misinformation about GLP-1s to the public. The FDA warns that using unapproved versions of GLP-1 drugs can be risky for patients. This story was updated on September 4, 2025 to include responses from Eli Lilly and Novo Nordisk Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments

How does TrimRx ensure safety and effectiveness

Add Healthy Fats Omega-3s (from wild fish, flax, and chia) and medium-chain triglycerides (from coconut oil) support GLP-1 release and reduce inflammation

Participate in the next discovery About the Author James Ashenhurst , Ph.D

This predictable pattern allows you to plan your entire week around your injection schedule rather than being surprised by fluctuations